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Secondary envelopment of herpes simplex virus type 1 has been demonstrated as taking place at
the trans-Golgi network (TGN). The inner tegument proteins pUL36 and pUL37 and the envelope
glycoproteins gD and gE are known to be important for secondary envelopment. We compared
the cellular localizations of capsids from a virus mutant lacking the UL37 gene with those of a virus
mutant lacking the genes encoding gD and gE. Although wild-type capsids accumulated at the
TGN, capsids of the pUL37
” mutant were distributed throughout the cytoplasm and showed no
association with TGN-derived vesicles. This was in contrast to capsids from a gD
”gE
” mutant,
which accumulated in the vicinity of TGN vesicles, but did not colocalize with them, suggesting
that they were transported to the TGN but were unable to undergo envelopment. We conclude
that the inner tegument protein pUL37 is required for directing capsids to the TGN, where
secondary envelopment occurs.
Morphogenesis of the herpesvirus particle begins when the
capsid is formed in the nucleus of an infected cell (Homa &
Brown,1997).Thecapsid exitsthenucleus bybudding atthe
inner nuclear membrane, thus gaining a primary envelope,
which then fuses with theouternuclearmembrane,releasing
the capsid into the cytosol (Mettenleiter et al., 2006). How
the capsid then acquires the bulk of the tegument and
undergoes secondary envelopment is not clear. The trans-
Golgi network (TGN) appears to be an important site of
envelopment where glycoproteins and tegument proteins
accumulate (Sugimoto et al., 2008; Turcotte et al., 2005).
The fact that TGN targeting of these proteins can occur
independently of the presence of capsids has been shown
directly for several glycoproteins (Turcotte et al., 2005) and
is supported by the observation that L-particles, consisting
of enveloped tegument, are formed under conditions where
capsidformationisblocked(Rixonetal.,1992;Robertsetal.,
2009). A number of viral proteins have been implicated in
the secondary envelopment process of herpes simplex virus
type 1 (HSV-1) or pseudorabies virus, including the
glycoproteins gD, gE, gI and gM (Brack et al., 1999;
Farnsworth et al., 2003), the envelope protein pUL20
(Baines et al., 1991; Foster et al., 2004) and the tegument
proteins pUL48 (Mossman et al., 2000), pUL11 (Baines &
Roizman, 1992; Leege et al., 2009), pUL36 and pUL37
(Desai, 2000; Desai et al., 2001; Roberts et al., 2009). The
inner tegument proteins pUL36 and pUL37 interact with
each other and the interaction is conserved across members
of the family Herpesviridae (Bechtel & Shenk, 2002; Klupp
etal.,2002;Mijatovetal.,2007;Rozenetal.,2008;Uetzetal.,
2006; Vittone et al., 2005). Both proteins are components of
both infectious virions and L-particles (McLauchlan et al.,
1994; Szilagyi & Cunningham, 1991). Their presence in L-
particles implies that their interaction with outer tegument
proteins does not depend on the presence of capsids. This
was confirmed by recent studies showing that pUL37
associates with the TGN of infected cells and that this
localization depends on the presence of pUL36, but not of
capsids (Desai et al., 2008). Furthermore, studies with
deletion mutants have shown that pUL36 and pUL37 are
mutually co-dependent for incorporation into L-particles,
suggesting that they normally occur as a complex (Roberts
et al., 2009). pUL36 has been reported to interact with the
outer tegument protein pUL48 (Vittone et al., 2005) and to
be important for its incorporation in virions (Ko et al.,
2009). pUL48, in turn, binds to several other tegument
proteins and glycoproteins, including pUL46, pUL49 and
gH (Elliott et al., 1995; Gross et al., 2003; Lee et al., 2008;
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with the minor capsid protein pUL25 (Coller et al., 2007;
Pasdeloup et al., 2009), and pUL37 has been reported to
interact with pUL46 in a yeast two-hybrid assay (Lee et al.,
2008). Both pUL36 and pUL37 have essential roles in virion
assembly, and virus mutants deleted for either gene
accumulate large numbers of unenveloped capsids in the
cytoplasm of infected cells (Desai, 2000; Desai et al., 2001;
Fuchs et al., 2004; Klupp et al., 2001; Roberts et al., 2009).
Taken together, these observations identify pUL36 and
pUL37 as likely candidates to act as a bridge between the
capsid and the outer tegument and envelope compartments
during virion assembly. Therefore, we compared the
behaviour of a UL37-null mutant with that of a gD-/gE-
null virus to examine the role of these proteins in targeting
capsids to the TGN.
As we wished to observe the behaviour of intracellular
capsids and to avoid the poor antibody labelling typically
seen with wild-type (WT) HSV-1 capsids, we generated a
number of viruses encoding a fluorescently tagged capsid
protein. In vVP26GFP, the green fluorescent protein (GFP)
fused to the N terminus of the small capsid protein VP26
(Desai & Person, 1998) was recombined into the WT HSV-1
(strain 17+) genome. vVP26GFP was then used to generate
the UL37
2 virus vFRD37-VP26GFP by co-infecting the
pUL37-expressing cell line 80C02 with FRDUL37 (Roberts
et al., 2009) and vVP26GFP and selecting plaques exhibiting
both GFP fluorescence and a defect in growth on non-
complementing rabbit skin (RS) cells.
To screen vFRD37-VP26GFP for fusion of GFP to VP26
and for the absence of pUL37, RS cells were infected for
24 h with WT HSV-1, vVP26GFP or vFRD37-VP26GFP.
The cells were then harvested and analysed by Western blot
analysis using GFP-, VP26- and UL37-specific antibodies
[see Supplementary Methods (available in JGV Online) for
antibody details]. Fig. 1(a) shows that pUL37 is present in
WT HSV-1-infected and vVP26GFP-infected cells (lanes 4
and 3, respectively), but is missing from vFRD37-
VP26GFP-infected cells (lane 2). The VP26-specific
antibody recognizes a band of 14 kDa in WT HSV-1-
infected cells (lane 4, right), but this band is missing in
vFRD37-VP26GFP-infected and vVP26GFP-infected cells
(lanes 2 and 3, right), where a band of approximately 40–
45 kDa is recognized by both VP26- and GFP-specific
antibodies. This band is of the approximate size expected
for the GFP–VP26 fusion protein (39 kDa).
To compare the growth characteristics of vFRD37-
VP26GFP, vVP26GFP and WT HSV-1, virus stocks were
titrated on complementing and non-complementing cells.
This confirmed that the D37 mutation was lethal for virus
growth, with a reduction in titre of .10
5 (Fig. 1c). Single-
step growth-curve analysis on the complementing cell line
showed that vFRD37-VP26GFP grew with similar kinetics
to WT HSV-1 and vVP26GFP, but reached a slightly lower
titre (around 7% lower) after 24 h (see Supplementary Fig.
S1, available in JGV Online).
The combined absence of glycoproteins gD and gE
prevents virus budding and results in accumulation of
tegumented, unenveloped capsids in the cytoplasm
(Farnsworth et al., 2003). In order to compare this well-
characterized phenotype with that observed with vFRD37-
VP26GFP, we used vgD-gE-VP26RFP, which contains both
a red fluorescent protein (RFP)-tagged VP26 and a gD–gE
deletion. The vgD-gE-VP26RFP virus was obtained by co-
infecting the gD-expressing cell line VD60 with
vUL35RFP1D1, a virus containing an RFP-tagged VP26,
and the gD
2,g E
2 virus vRR1097-gEb (Farnsworth et al.,
2003) (see Supplementary Methods for details of virus
constructions).
We first characterized these viruses with regard to their
growth defect. Titration of virus stocks on complementing
(VD60) and non-complementing (Vero) cells confirmed
that the deletion of the US6 open reading frame encoding
gD was lethal for virus growth, with a reduction in titre of
¢10
5 for vgD-gE-VP26RFP (Fig. 1c). The higher back-
ground level of vgD-VP26RFP seen on the non-comple-
menting cell line was a result of recombination between the
mutant genome and the extensive virus sequences used to
make the complementing cell line (Ligas & Johnson, 1988).
The protein-expression phenotypes of the virus mutants
were examined by infecting non-complementing Vero cells
with 5 p.f.u. of WT HSV-1, vRR1097-gEb, vUL35RFP1D1,
vgD-VP26RFP or vgD-gE-VP26RFP per cell and by
analysing cell lysates by Western blotting using antibodies
against VP26, gD and gE (Fig. 1b). Glycoproteins gD and
gE were detected as a pattern of bands, reflecting different
states of glycosylation and maturation of the proteins
(Cohen et al., 1978). These bands were present in WT
HSV-1- and vUL35RFP1D1-infected cells (lanes 1 and 3)
and absent from vRR1097-gEb- and vgD-gE-VP26RFP-
infected cells (lanes 2 and 5). As expected, the vgD-
VP26RFP-infected cell lysate showed the presence of gE
and the absence of gD (lane 4). The fusion of RFP to VP26
was confirmed by the shift in molecular mass of VP26 from
approximately 14 kDa in WT HSV-1- and vRR1097-gEb-
infected cells (lanes 1 and 2) to approximately 40 kDa in
vUL35RFP1D1-, vgD-VP26RFP- and vgD-gE-VP26RFP-
infected cells (lanes 3–5). This experiment confirmed the
absence of gD and gE and the fusion of RFP to VP26 in the
newly engineered vgD-gE-VP26RFP virus.
To examine the effect of the UL37 and gD–gE mutations on
capsid association with the TGN, HFFF2 (human fetal
foreskin fibroblasts; European Collection of Cell Cultures)
and HeLa cells were infected for 15, 18 or 24 h with 5 p.f.u.
of vVP26GFP, vFRD37-VP26GFP, vUL35RFP1D1 or vgD-
gE-VP26RFP per cell, and stained for the TGN using the
anti-TGN46 antibody (Fig. 2) or for the Golgi with the anti-
giantinantibody(seeSupplementaryFig.S2,availableinJGV
Online). Similar results were observed at all times post-
infection and only the 15 h images are shown. The TGN is
disrupted into small vesicles upon infection by HSV-1, as
described previously (Campadelli et al.,1 9 9 3 ) .I na l lc a s e s ,
the patterns of association between capsids and TGN vesicles
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cytoplasmic capsids formed aggregates in vFRD37-
VP26GFP-infected HFFF2 cells, as described previously for
other UL37
2 mutants (Desai et al., 2001; Klupp et al., 2001;
Roberts et al., 2009), aggregates were not seen in HeLa cells,
where their absence made it easier to observe the behaviour
of individual capsids. Many of the capsids in the control
vVP26GFP- and vUL35RFP1D1-infected cells colocalized
with TGN vesicles, although they were also present in other
regions of the cytoplasm (Fig. 2a, b). In the case of vgD-gE-
VP26RFP, capsids accumulated in clusters adjacent to, but
separated from, TGN vesicles (Fig. 2b). The tendency of
capsids to aggregate in the absence of gD and gE was
described previously for the parental mutant, vRR1097-gEb
(Farnsworth et al., 2003). In contrast to the juxtaposition of
capsids and TGN seen with vgD-gE-VP26RFP, vFRD37-
VP26GFP capsids accumulated throughout the cytoplasm of
infected cells, without exhibiting any association with
TGN46- or giantin-positive vesicles (Fig. 2a; Supple-
mentary Fig. S2). The differing behaviours of vFRD37-
VP26GFP and vgD-gE-VP26RFP were not due to capsid
aggregation, as vFRD37-VP26GFP capsids also failed to
associate with TGN in HFFF2 cells, where large aggregates
formed readily (Fig. 2d). Quantification of the fluorescence
signals confirmed that there was a significant decrease
(approx. 90%) in the level of colocalization of vFRD37-
VP26GFP and vgD-gE-VP26RFP capsids with TGN, com-
pared with their corresponding controls (Fig. 2c). To
Fig. 1. Characterization of the vFRD37-VP26GFP and vgD-gE-VP26RFP viruses. (a) RS cells were mock-infected (lane 1) or
infected with 5 p.f.u. of vFRD37-VP26GFP (lane 2), vVP26GFP (lane 3) or WT HSV-1 (lane 4) per cell and harvested after
24 h. Proteins were analysed by Western blotting using the pUL37 antibody, together with either the GFP-specific antibody
(left panel) or the VP26-specific antibody (right panel). Note that a viral protein migrating at approximately 75 kDa is recognized
non-specifically by the pUL37 antibody. Molecular mass markers (in kDa) are indicated to the left of the figure. (b) Vero cells
were infected with 5 p.f.u. of WT HSV-1 (lane 1), vRR1097-gEb (lane 2), vUL35RFP1D1 (lane 3), vgD-VP26RFP (lane 4) or
vgD-gE-VP26RFP (lane 5) per cell or were mock-infected (lane 6), and harvested after 24 h. Proteins were analysed by
Western blotting using a gD antibody, a gE antibody and a VP26-specific antibody. Molecular mass markers (in kDa) are
indicated to the right of the figure. (c) Growth of viruses on complementing (filled bars) and non-complementing (empty bars)
cell lines. Concentrated stocks of virus were titrated on RS cells (vVP26GFP), Vero cells (vUL35RFP1D1, vgD-VP26RFP, vgD-
gE-VP26RFP), 80C02 cells [a clone of RS cells expressing UL37 (Roberts et al., 2009)] (vFRD37-VP26GFP) or VD60 cells [a
clone of Vero cells expressing gD (Ligas & Johnson, 1988)] (vgD-VP26RFP, vgD-gE-VP26RFP). *vVP26GFP and
vUL35RFP1D1 were not tested on complementing cells. **The titres of vFRD37-VP26GFP and vgD-gE-VP26RFP on non-
complementing cells were assigned as ,10
3 because the input virus caused severe cytopathic effects at lower dilutions.
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Fig. 2. Association of capsids with the TGN. (a) HeLa cells were infected with 5 p.f.u. of vVP26GFP or vFRD37-VP26GFP per
cell. At 15 h post-infection, the cells were fixed and stained with anti-TGN46 antibody and a GAR568 antibody (red). Capsids
were visualized through direct GFP fluorescence (green). Bar, 10 mm. (b) HeLa cells were infected with 5 p.f.u. of
vUL35RFP1D1 or vgD-gE-VP26RFP per cell. At 15 h post-infection, cells were fixed and labelled with anti-TGN46 antibody
and a GARCy5 antibody (pseudo-coloured in green). Capsids were visualized through direct RFP fluorescence (red). In all
cases, nuclei were stained with DAPI (blue). The boxed regions in the Merge+DAPI images are shown enlarged in the final
panel and the positions of some TGN-derived vesicles are indicated by arrowheads. (c) Quantification of the amount of TGN
signal that colocalizes with capsid signal for the four different viruses in HeLa cells (1, vVP26GFP; 2, vFRD37-VP26GFP; 3,
vUL35RFP1D1; 4, vgD-gE-VP26RFP). The numbers of fields of view analysed are indicated above each bar. (d) HFFF2 cells
were infected with 5 p.f.u. of vFRD37-VP26GFP per cell and labelled as above. A capsid aggregate is indicated by an arrow
and a TGN vesicle by an arrowhead. Bars, 5 mm.
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influencing the behaviour of capsids, the experiments were
repeated using the original untagged versions of the mutants,
vFRDUL37 and vRR1097-gEb (see Supplementary Fig. S3,
available in JGV Online). In agreement with previous results,
WT capsids were largely colocalized with TGN vesicles and
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Fig. 3. Effect of UL37 and gD–gE deletions on the localization of glycoproteins and tegument proteins. (a) HeLa cells infected
with vgD-gE-VP26RFP for 15 h were fixed and labelled with the anti-pUL36 antibody and a GAM633 antibody (pseudo-
coloured in green) or were permeabilized with digitonin and labelled with anti-pUL37 antibody and a GARCy5 antibody (pseudo-
coloured in green) under native conditions as described by Copeland et al. (2009). Bar, 5 mm. (b) HeLa cells were infected with
vFRD37-VP26GFP for 15 h, fixed and labelled with anti-pUL36 antibody and a GAR568 antibody (red). (c) HeLa cells were
infected with 5 p.f.u. of vVP26GFP or vFRD37-VP26GFP per cell. At 15 h post-infection, cells were fixed and labelled with
TGN46-specific antibody and a GARCy5 antibody to label the TGN (blue), and with a gD-specific antibody and a GAM568
antibody to label gD (red). Capsids were visualized through direct GFP fluorescence (green). (d) Cells were infected and
treated as in (c) except that the gD-specific antibody was replaced by pUL48-specific antibody to label pUL48 (red).
Arrowheads in (c) and (d) indicate the positions of some TGN-derived vesicles. Bars, 10 mm.
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TGN vesicles, whereas vFRDUL37 capsids were widely
dispersed and showed no association with the TGN.
As lack of both the inner tegument protein pUL37 and the
envelope glycoproteins gD–gE blocked the colocalization of
capsids with the TGN, it was important to show that these
two classes of structural protein were functioning inde-
pendently. Immunofluorescence using the anti-UL36 or
anti-pUL37 antibody revealed extensive colocalization
between pUL36 or pUL37 and vgD-gE-VP26RFP capsid
clusters (Fig. 3a). The presence of pUL36 and UL37 implies
that the failure of capsids to gain an envelope was a direct
result of the absence of the glycoproteins and not due to a
block on the association between these capsids and inner
tegument proteins. Moreover, we could exclude the
possibility that the phenotype observed in vFRD37-
VP26GFP-infected cells was due to a possible absence of
pUL36 on capsids, as vFRD37-VP26GFP capsids were
stained for pUL36 using the anti-UL36 antibody (Fig. 3b).
To examine whether localization of viral glycoproteins to
the TGN was affected by the lack of pUL37, vVP26GFP-
and vFRD37-VP26GFP-infected cells were stained for
TGN46 and the glycoprotein gD. In both cases, gD was
found on all TGN vesicles (Fig. 3c), either in association
with capsids (vVP26GFP-infected cells) or in their absence
(vFRD37-VP26GFP-infected cells). Similar observations
were made with gI and gE (data not shown), demonstrat-
ing that pUL37 is not required to direct any of these
glycoproteins to the TGN. Similarly, examination of the
outer tegument protein pUL48 showed its presence at the
TGN in both vVP26GFP- and vFRD37-VP26GFP-infected
cells (Fig. 3d). Thus, the absence of pUL37 appears to block
envelopment by directly preventing the targeting of capsids
to the TGN, rather than by interfering with the localization
of envelopment-related glycoproteins or outer tegument
proteins. It is clear, therefore, that the maturation defects
observed in the inner tegument protein and glycoprotein
mutants are different in nature, with pUL37 being required
to direct capsids to the TGN, and gD and gE being needed
for their envelopment once they have arrived there.
The mechanism by which pUL37 helps guide capsids to
the TGN is unclear. Directed movement would require the
involvement of cellular factors, which might be expected
to be recruited to capsids by interacting with pUL37 or
with its inner tegument partner, pUL36. However, any
such factors remain to be identified. Although our data
support a role for pUL37 in directing capsids to the TGN,
this does not preclude involvement in later stages of
envelopment.
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